Michael Eby
Impact in
- Cancer Research top 0.5%
- NF-κB Signaling Pathways
- Immunology top 1%
- Immune Response and Inflammation
- interferon and immune responses
- Immune Cell Function and Interaction
Papers in
-
- Cell death mechanisms and regulation 6
- Ubiquitin and proteasome pathways 3
- Melanoma and MAPK Pathways 2
- Immunology 10
- interferon and immune responses 5
- Immune Response and Inflammation 4
- Invertebrate Immune Response Mechanisms 2
- Co-authors
- Preet M. Chaudhary (13 shared papers)Alan Jasmin (9 shared papers)Leroy Hood (6 shared papers)Karen O’Rourke (4 shared papers)Vishva M. Dixit (4 shared papers)Somasekar Seshagiri (5 shared papers)Ingrid E. Wertz (2 shared papers)Honglin Zhou (2 shared papers)
- Journals
- Journal of Biological Chemistry (4 papers)Oncogene (4 papers)Cancer Biology & Therapy (2 papers)Science (2 papers)Nature (2 papers)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Michael Eby
19 papers receiving 4.7k citations
Michael Eby's Hit Papers
Peers
Comparison fields: 5 of 109
- Cancer Research 1.8k
- Immunology 2.3k
- Oncology 1.2k
- Molecular Biology 2.8k
- Epidemiology 639
Countries citing papers authored by Michael Eby
This map shows the geographic impact of Michael Eby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Eby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Eby more than expected).
Fields of papers citing papers by Michael Eby
This network shows the impact of papers produced by Michael Eby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Eby. The network helps show where Michael Eby may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Eby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling Hit paper breakdown → | 2004 | 1516 |
| 2 | Death Receptor 5, a New Member of the TNFR Family, and DR4 Induce FADD-Dependent Apoptosis and Activate the NF-κB Pathway Hit paper breakdown → | 1997 | 603 |
| 3 | 2003 | 436 | |
| 4 | 2007 | 380 | |
| 5 | 1999 | 250 | |
| 6 | 2000 | 209 | |
| 7 | 2002 | 197 | |
| 8 | 1998 | 188 | |
| 9 | 2006 | 185 | |
| 10 | 2003 | 138 | |
| 11 | 2001 | 138 | |
| 12 | 2002 | 120 | |
| 13 | 2006 | 112 | |
| 14 | 2000 | 103 | |
| 15 | 1999 | 50 | |
| 16 | 1998 | 30 | |
| 17 | 2002 | 29 | |
| 18 | 2006 | 24 | |
| 19 | 2001 | 21 |
About Michael Eby
Michael Eby is a scholar working on Molecular Biology, Immunology, Cancer Research, Oncology and Organic Chemistry, having authored 19 papers that have together received 4.7k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (9 papers), Cell death mechanisms and regulation (6 papers), interferon and immune responses (5 papers), Immune Response and Inflammation (4 papers), Cancer-related Molecular Pathways (3 papers), Ubiquitin and proteasome pathways (3 papers), Invertebrate Immune Response Mechanisms (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Cancer Research (1.8k citations), Immunology (2.3k citations), Oncology (1.2k citations), Molecular Biology (2.8k citations) and Epidemiology (639 citations). Michael Eby has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Preet M. Chaudhary, Alan Jasmin, Leroy Hood, Karen O’Rourke, Vishva M. Dixit, Somasekar Seshagiri, Ingrid E. Wertz, Honglin Zhou, Arvind Kumar and Christian Wiesmann. Their work appears in journals such as Journal of Biological Chemistry, Oncogene, Cancer Biology & Therapy, Science and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.